Law360, New York (April 11, 2008) -- A British appellate court has overturned a ruling that found claims in H. Lundbeck A/S’ patent for its antidepressant drug Cipralex insufficient, scoring a win for the Danish pharmaceutical company in an ongoing patent challenge brought by three generics makers.
In a sweeping victory for Lundbeck, a three-judge panel in the Supreme Court of Judicature, Court of Appeal in England and Wales overturned part of the lower court’s ruling that...
